We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+28.88%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$453M
AUM Growth
-$9.38M
Cap. Flow
-$94.9M
Cap. Flow %
-20.93%
Top 10 Hldgs %
21.21%
Holding
909
New
156
Increased
102
Reduced
243
Closed
406

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$44.3M
2
MSFT icon
Microsoft
MSFT
+$6.19M
3
ACN icon
Accenture
ACN
+$5.66M
4
BIIB icon
Biogen
BIIB
+$4.48M
5
UAL icon
United Airlines
UAL
+$3.29M

Sector Composition

Rank Sector Weight
1 Technology 20.06%
2 Consumer Discretionary 12.14%
3 Healthcare 10.09%
4 Consumer Staples 9.74%
5 Industrials 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CF icon
551
CF Industries
CF
$18.4B
-16,856
Closed -$458K
CHH icon
552
Choice Hotels
CHH
$5.15B
-4,597
Closed -$282K
CLB icon
553
Core Laboratories
CLB
$518M
-14,073
Closed -$146K
CMA
554
DELISTED
Comerica
CMA
-19,820
Closed -$582K
CMC icon
555
Commercial Metals
CMC
$7.53B
-35,777
Closed -$565K
CMCSA icon
556
Comcast
CMCSA
$80.9B
-77,900
Closed -$2.68M
CNDT icon
557
Conduent
CNDT
$234M
-43,200
Closed -$106K
CNO icon
558
CNO Financial Group
CNO
$4.96B
-10,200
Closed -$126K
COLL icon
559
Collegium Pharmaceutical
COLL
$1.15B
-14,300
Closed -$234K
COOP
560
DELISTED
Mr. Cooper
COOP
-10,623
Closed -$78K
COP icon
561
ConocoPhillips
COP
$141B
-17,730
Closed -$546K
CORT icon
562
Corcept Therapeutics
CORT
$9.78B
-19,400
Closed -$231K
CPB icon
563
Campbell Soup
CPB
$6.67B
-5,618
Closed -$259K
CPRX
564
DELISTED
Catalyst Pharmaceutical
CPRX
-12,003
Closed -$46K
CPRI icon
565
Capri Holdings
CPRI
$1.82B
-29,197
Closed -$315K
CRON
566
Cronos Group
CRON
$1.07B
-11,167
Closed -$63K
CRSP icon
567
CRISPR Therapeutics
CRSP
$4.6B
-6,200
Closed -$263K
CSGS
568
DELISTED
CSG Systems International
CSGS
-5,147
Closed -$215K
CSIQ icon
569
Canadian Solar
CSIQ
$936M
-57,353
Closed -$912K
CSX icon
570
CSX Corp
CSX
$96B
-44,205
Closed -$844K
CTRA
571
DELISTED
Coterra Energy
CTRA
-11,069
Closed -$190K
CTSH icon
572
Cognizant
CTSH
$22.3B
-11,186
Closed -$520K
CVX icon
573
Chevron
CVX
$378B
-2,814
Closed -$204K
DAN icon
574
Dana Inc
DAN
$2.93B
-13,000
Closed -$102K
DAR icon
575
Darling Ingredients
DAR
$9.62B
-11,558
Closed -$222K

Similar funds

Bayesian Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Bayesian Capital Management held 909 positions worth $453M, down 2% from $463M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bayesian Capital Management withdrew a net $94.9M in Q2 2020, closing 406 positions and reducing 243 holdings. Its most notable exit was ExxonMobil, an estimated $4.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $46.7M.

  • Bayesian Capital Management's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 151,500 shares worth $46.7M.
  • Bayesian Capital Management added most to Biogen in Q2 2020, an estimated $4.48M increase.
  • Bayesian Capital Management's biggest Q2 2020 reduction was Walgreens Boots Alliance, cutting an estimated $11.2M.
  • Bayesian Capital Management fully exited ExxonMobil in Q2 2020, selling an estimated $4.17M.
  • Bayesian Capital Management's ten largest holdings make up 21% of its $453M portfolio in Q2 2020.
  • Bayesian Capital Management opened 156 new positions and closed 406 in Q2 2020.
  • Bayesian Capital Management's portfolio value fell 2% quarter-over-quarter to $453M.

Based on Bayesian Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.